Chargement en cours...
Methotrexate decreases tenofovir exposure in antiretroviral-suppressed individuals living with HIV
BACKGROUND: To mitigate increased risk of premature cardiovascular disease in antiretroviral therapy (ART) suppressed adults living with HIV (PWH), low dose methotrexate (LDMTX) was evaluated in a multicenter randomized placebo controlled clinical trial of 176 PWH taking various ART regimens (ACTG A...
Enregistré dans:
| Publié dans: | J Acquir Immune Defic Syndr |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132144/ https://ncbi.nlm.nih.gov/pubmed/33177476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002502 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|